Health Library
March 3, 2026
Question on this topic? Get an instant answer from August.
• The 15 mg weekly dose of Zepbound produced greatest average weight loss in clinical trials: about 20.9% of body weight (roughly 48 lbs) over 72 weeks.
• The 10 mg dose came close at 19.5% (about 44 lbs), while 5 mg dose delivered 15% (about 34 lbs).
• Everyone starts at 2.5 mg and increases by 2.5 mg every four weeks. The approved maintenance doses are 5 mg, 10 mg, and 15 mg.
• The "most effective" dose is highest one you can tolerate comfortably. Many people do extremely well at 10 mg without needing to push to 15 mg.
• Side effects (mainly nausea, diarrhea, and vomiting) are most common during dose increases, not at steady maintenance.
Zepbound (tirzepatide) is not a medication where you start at full dose on day one. The dosing follows a structured escalation schedule designed to give your body time to adjust.
You begin at 2.5 mg injected once per week. This is not a maintenance dose. It is purely for tolerability. After four weeks at 2.5 mg, you move up to 5 mg. From there, your provider can continue increasing dose by 2.5 mg every four weeks, moving through 7.5 mg, 10 mg, 12.5 mg, and potentially up to 15 mg.
The three approved maintenance doses are 5 mg, 10 mg, and 15 mg. The inbetween strengths (7.5 mg and 12.5 mg) are transitional doses used during ramp up period. They were not studied as standalone maintenance doses in SURMOUNT clinical trials. The FDA prescribing label outlines this titration schedule and three target maintenance levels.
This gradual approach is important. Starting too high would cause significant gastrointestinal side effects for most people. The four week intervals at each step let your gut adapt to medication before dose goes up again.
The SURMOUNT 1 trial is largest and most frequently cited study. It followed adults with obesity (without diabetes) over 72 weeks. Participants were randomized to Zepbound 5 mg, 10 mg, 15 mg, or placebo, all alongside a reduced calorie diet and increased physical activity.
The results showed a clear dose dependent response. People on 5 mg lost an average of 15% of their body weight, which worked out to about 34 pounds. People on 10 mg lost an average of 19.5%, or roughly 44 pounds. And people on 15 mg lost an average of 20.9%, about 48 pounds. Placebo produced just 3.1% weight loss.
Looking at specific milestones, 91% of people on 15 mg dose achieved at least 5% weight loss. More impressively, a substantial proportion hit 20% or more, which is a threshold that was nearly impossible to reach with older weight loss medications.
The more recent SURMOUNT 5 trial compared Zepbound head to head against semaglutide (Wegovy) for first time. At 72 weeks, Zepbound at maximum tolerated dose (10 mg or 15 mg) produced an average weight loss of 20.2% (about 50 pounds), compared to 13.7% (about 33 pounds) for semaglutide. That is a 47% greater weight reduction.

On paper, 15 mg is most effective dose. But "most effective on average across a clinical trial" and "most effective for you personally" are two different things.
The jump from 5 mg to 10 mg is where biggest increase in weight loss happens, roughly 5 additional percentage points. The jump from 10 mg to 15 mg adds another 1 to 2 percentage points on average. That is still meaningful, but it is a smaller marginal gain.
At same time, higher doses come with a higher rate of gastrointestinal side effects. Nausea, diarrhea, vomiting, and constipation are most commonly reported issues, and they tend to be most noticeable during dose escalation rather than once you have stabilized at a maintenance dose. In SURMOUNT 1, discontinuation rates due to side effects were similar across dose groups (around 4 to 7%), which suggests most people adapted. But individual tolerance varies a lot.
For some people, 10 mg delivers excellent results with manageable side effects. Pushing to 15 mg in that case might add modest extra weight loss but at cost of comfort and quality of life. Your provider should help you weigh whether incremental benefit of a higher dose is worth it for your specific situation.
If you are wondering about what happens after you reach your target weight and how dosing decisions play into long term management, on tirzepatide maintenance dosing after weight loss those considerations.
If side effects become too difficult at a particular dose, standard approach is to stay at that dose for longer than four weeks before attempting another increase. Giving your body more time to adjust often resolves issue.
If side effects persist, your provider may decide that your current dose is your maintenance dose, even if it is lower than 15 mg. Staying at 5 mg or 10 mg is not a failure. Both doses produce clinically meaningful weight loss that far exceeds what most other treatments can achieve.
Some of most common GI symptoms during dose changes include nausea, sulfur tasting burps, bloating, and loose stools. These tend to peak in first few days after an increase and improve over following weeks. For a closer look at one of more specific side effects people report during titration, this piece on sulfur burps with Zepbound covers what causes them and how to manage them.
Eating smaller meals, avoiding high fat foods, and staying hydrated can all help ease GI symptoms during dose adjustments. Your provider may also suggest temporary dietary modifications while your body is adapting.
Weight loss with Zepbound is progressive throughout treatment period. In clinical trials, weight continued to decrease through week 60 to 72 at all doses, meaning medication keeps working over time rather than producing a quick initial drop that plateaus early.
The rate of loss is somewhat faster at higher doses, but pattern is gradual across board. Most people notice meaningful changes within first month or two, particularly in appetite reduction and portion sizes. Visible weight loss on scale tends to accelerate after first dose increase or two.
It is also worth noting that clinical trials paired medication with a reduced calorie diet (typically a 500 calorie daily deficit) and at least 150 minutes of moderate physical activity per week. Zepbound makes those lifestyle changes significantly easier by reducing hunger and increasing fullness, but combination of medication plus behavior change is what produced trial results.
Yes. Dose reductions are a normal part of treatment. If you have reached your goal weight or if side effects at a higher dose are not manageable, your provider can step you back down to a lower maintenance dose.
The SURMOUNT 4 trial specifically looked at what happens when people stop Zepbound after losing weight. Participants who were switched to placebo regained a significant portion of their lost weight, while those who continued on tirzepatide maintained their results. This reinforces that continued treatment, even at a lower maintenance dose, is important for keeping weight off long term.
The 15 mg dose of Zepbound produces highest average weight loss in clinical data, around 21% of body weight over 72 weeks. But 10 mg dose comes remarkably close and may be right stopping point for many people. The best dose is one that gives you meaningful, sustained results while keeping side effects manageable.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.